Induction of Long-Lasting Regulatory B Lymphocytes by Modified Immune Cells in Kidney Transplant Recipients

被引:6
|
作者
Morath, Christian [1 ,2 ]
Schaier, Matthias [1 ,2 ]
Ibrahim, Eman [3 ,4 ]
Wang, Lei [2 ,5 ]
Kleist, Christian [3 ,6 ]
Opelz, Gerhard [3 ]
Suesal, Caner [3 ,7 ]
Ponath, Gerald [1 ,2 ]
Aly, Mostafa [1 ,3 ,8 ]
Alvarez, Cristiam M. [9 ]
Kaelble, Florian [1 ]
Speer, Claudius [1 ]
Benning, Louise [1 ]
Nusshag, Christian [1 ]
da Silva, Luiza Pego [1 ]
Sommerer, Claudia [1 ]
Hueckelhoven-Krauss, Angela [5 ]
Czock, David [10 ]
Mehrabi, Arianeb [11 ]
Schwab, Constantin [12 ]
Waldherr, Ruediger [12 ]
Schnitzler, Paul [13 ]
Merle, Uta [14 ]
Thuong Hien Tran [3 ]
Scherer, Sabine [3 ]
Boehmig, Georg A. [15 ]
Mueller-Tidow, Carsten [5 ]
Reiser, Jochen [16 ]
Zeier, Martin [1 ]
Schmitt, Michael [5 ]
Terness, Peter [3 ]
Schmitt, Anita [2 ,5 ]
Daniel, Volker [3 ]
机构
[1] Heidelberg Univ Hosp, Dept Nephrol, Neuenheimer Feld 162, D-69120 Heidelberg, Germany
[2] TolerogenixX GmbH, Heidelberg, Germany
[3] Heidelberg Univ Hosp, Inst Immunol, Heidelberg, Germany
[4] Assiut Univ, South Egypt Canc Inst, Clin Pathol Dept, Assiut, Egypt
[5] Heidelberg Univ Hosp, Dept Hematol Oncol & Rheumatol, Heidelberg, Germany
[6] Heidelberg Univ Hosp, Dept Nucl Med, Heidelberg, Germany
[7] Kog Univ, Transplant Immunol Res Ctr Excellence, Istanbul, Turkiye
[8] Assiut Univ, Internal Med Dept, Nephrol Unit, Assiut, Egypt
[9] Univ Antioquia, Fac Med, Cellular Immunol & Immunogenet Grp, Medellin, Colombia
[10] Heidelberg Univ Hosp, Dept Clin Pharmacol & Pharmacoepidemiol, Heidelberg, Germany
[11] Heidelberg Univ Hosp, Dept Gen Visceral & Transplantat Surg, Heidelberg, Germany
[12] Heidelberg Univ Hosp, Inst Pathol, Heidelberg, Germany
[13] Heidelberg Univ Hosp, Ctr Infect Dis, Virol, Heidelberg, Germany
[14] Heidelberg Univ Hosp, Dept Gastroenterol, Heidelberg, Germany
[15] Med Univ Vienna, Dept Med 3, Div Nephrol & Dialysis, Vienna, Austria
[16] Rush Univ, Dept Med, Chicago, IL 60612 USA
来源
关键词
clinical trial; immunosuppression; kidney transplantation; regulatory B lymphocytes; tolerance; MITOMYCIN-C; ALLOGRAFT SURVIVAL; BLOOD-CELLS; OPERATIONAL TOLERANCE; DENDRITIC CELLS; SIGNATURE; REJECTION; PROLONGATION; INHIBITION; GENERATION;
D O I
10.1681/ASN.2022020210
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
BackgroundWe recently demonstrated that donor-derived modified immune cells (MICs)-PBMCs that acquire immunosuppressive properties after a brief treatment-induced specific immunosuppression against the allogeneic donor when administered before kidney transplantation. We found up to a 68-fold increase in CD19(+)CD24(hi)CD38(hi) transitional B lymphocytes compared with transplanted controls.MethodsTen patients from a phase 1 clinical trial who had received MIC infusions before kidney transplantation were followed to post-transplant day 1080.ResultsPatients treated with MICs had a favorable clinical course, showing no donor-specific human leukocyte antigen antibodies or acute rejections. The four patients who had received the highest dose of MICs 7 days before surgery and were on reduced immunosuppressive therapy showed an absence of in vitro lymphocyte reactivity against stimulatory donor blood cells, whereas reactivity against third party cells was preserved. In these patients, numbers of transitional B lymphocytes were 75-fold and seven-fold higher than in 12 long-term survivors on minimal immunosuppression and four operationally tolerant patients, respectively (P<0.001 for both). In addition, we found significantly higher numbers of other regulatory B lymphocyte subsets and a gene expression signature suggestive of operational tolerance in three of four patients. In MIC-treated patients, in vitro lymphocyte reactivity against donor blood cells was restored after B lymphocyte depletion, suggesting a direct pathophysiologic role of regulatory B lymphocytes in donor-specific unresponsiveness.ConclusionsThese results indicate that donor-specific immunosuppression after MIC infusion is long-lasting and associated with a striking increase in regulatory B lymphocytes. Donor-derived MICs appear to be an immunoregulatory cell population that when administered to recipients before transplantation, may exert a beneficial effect on kidney transplants.
引用
收藏
页码:160 / 174
页数:15
相关论文
共 50 条
  • [21] Regulatory T cells form stable and long-lasting cell cluster with myeloid dendritic cells (DC)
    Herman, Sonja
    Krenbek, Dagmar
    Klimas, Michael
    Bonelli, Michael
    Steiner, Carl W.
    Pietschmann, Peter
    Smolen, Josef S.
    Scheinecker, Clemens
    INTERNATIONAL IMMUNOLOGY, 2012, 24 (07) : 417 - 426
  • [22] Long-lasting complete response of metastatic melanoma to ipilimumab with analysis of the resident immune cells
    Birgit Tsaknakis
    Inga-Marie Schaefer
    Harald Schwörer
    Carsten-Oliver Sahlmann
    Kai-Martin Thoms
    Martina Blaschke
    Giuliano Ramadori
    Silke Cameron
    Medical Oncology, 2014, 31
  • [23] Long-lasting complete response of metastatic melanoma to ipilimumab with analysis of the resident immune cells
    Tsaknakis, Birgit
    Schaefer, Inga-Marie
    Schwoerer, Harald
    Sahlmann, Carsten-Oliver
    Thoms, Kai-Martin
    Blaschke, Martina
    Ramadori, Giuliano
    Cameron, Silke
    MEDICAL ONCOLOGY, 2014, 31 (01)
  • [24] Functional status of immune cells in patients with long-lasting type 2 diabetes mellitus
    Nam, H. W.
    Cho, Y. J.
    Lim, J. A.
    Kim, S. J.
    Kim, H.
    Sim, S. Y.
    Lim, D. G.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2018, 194 (01): : 125 - 136
  • [25] Long-term genotoxic effects of immunosuppressive drugs on lymphocytes of kidney transplant recipients
    Ciliao, Heloisa Lizotti
    de Oliveira Camargo-Godoy, Rossana Batista
    Mazzaron Barcelos, Gustavo Rafael
    Zanuto, Amanda
    Alvares Delfino, Vinicius Daher
    de Syllos Colus, Ilce Mara
    MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS, 2016, 806 : 47 - 52
  • [26] Regulatory CD25+T cells in human kidney transplant recipients
    Salama, AD
    Najafian, N
    Clarkson, MR
    Harmon, WE
    Sayegh, MH
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 (06): : 1643 - 1651
  • [27] Regulatory T cells in kidney transplant recipients: Active players but to what extent?
    Zhai, Y
    Kupiec-Weglinski, JW
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 (06): : 1706 - 1708
  • [28] IMMUNOSUPPRESSION AFFECTS CIRCULATING FOLLICULAR REGULATORY T CELLS IN KIDNEY TRANSPLANT RECIPIENTS
    Baan, Carla C.
    Niu, Qian
    Rojas, Aleixandra Mendoza
    Dieterich, Marjolein
    Wang, LanLan
    van Gelder, Teun
    Hesselink, Dennis A.
    van Besouw, Nicole M.
    TRANSPLANTATION, 2020, 104 (09) : S130 - S130
  • [29] Interactions of B and T Regulatory Cells in Normal Volunteers and in Tolerant HLA-Identical Kidney Transplant Recipients
    Mathew, J.
    Leventhal, J.
    Huang, X.
    Chen, L.
    Tambur, A.
    Friedewald, J.
    Abecassis, M.
    Miller, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 103 - 103
  • [30] Regulatory B Cells Profile in Kidney Transplant Recipients With Chronic- Active Antibody-Mediated Rejection
    Guzel, Halil Goksel
    Yilmaz, Vural Taner
    Koksoy, Sadi
    Kocak, Huseyin
    Kisaoglu, Abdullah
    Soylu, Mehmet
    Akkaya, Bahar
    Demiryilmaz, Ismail
    Aydinli, Bulent
    Suleymanlar, Gultekin
    TRANSPLANTATION PROCEEDINGS, 2023, 55 (05) : 1140 - 1146